FDA: Class I recall of BD Intraosseous Infusion System
Editor's Note The Food and Drug Administration (FDA) on August 11 classified the recall by Becton Dickinson (BD) of its Intraosseous Infusion System, which includes Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, and Intraosseous Powered Drivers, as Class I, the most serious. The recall was initiated for three separate…
Recovery of smell, taste after COVID-19 may take 6 months
Editor's Note This meta-analysis led by researchers at the National University of Singapore finds that recovery of the ability to taste and smell after COVID-19 infection may take up to 6 months, and women are more likely to experience loss of these senses and have a longer time to recovery.…
FDA: Class I recall of Haimen Shengbang Viral Transport Media Containers
Editor's Note The Food and Drug Administration (FDA) on August 9 identified the recall by Haimen Shengbang Laboratory Equipment Co Ltd of its Viral Transport Media Containers as Class I, the most serious. The recall was initiated because the products were distributed in the US without authorization, clearance, or approval…
Disparities in US COVID-19 vaccine distribution
Editor's Note This study led by researchers at the University of California, San Diego, finds that healthcare facilities in counties with higher Black composition and rural areas with large Hispanic populations were less likely to serve as COVID-19 vaccine administration locations during the initial rollout in May 2021. At that…
FDA: Class I recall of North American Diagnostics’ COVID-19 test
Editor's Note The Food and Drug Administration (FDA) on August 1 identified the recall by North American Diagnostics of its Oral Rapid SARS-CoV-2 Rapid Antigen Test Kits as Class I, the most serious. These tests are being recalled because they were distributed in the US without authorization, clearance, or approval…
Effectiveness of face shields for COVID-19 protection
Editor's Note This study led by researchers in the UK finds that face shields do not give high levels of protection against external droplet contamination. The researchers compared 13 styles of face shields in controlled laboratory settings, using a “coughing machine” that ejected fluorescent drops onto manikin heads. Among the…
FDA: Hospira recalls one lot of Propofol
Editor's Note The Food and Drug Administration (FDA), on July 13, posted a nationwide recall by Hospira Inc (a Pfizer Company) of one lot (DX9067) of Propofol Injectable Emulsion, USP (containing Benzyl alcohol), 100 mL single patient use glass fliptop vial. The recall was initiated because of visible particulate observed…
FDA: Class I recall of Covidien’s Palindrome, Mahurkar hemodialysis catheters
Editor's Note The Food and Drug Administration (FDA) on July 28 identified the recall by Covidien, LLC (Medtronic) of its Palindrome and Mahurkar hemodialysis catheters as Class I, the most serious. The recall was initiated because of a catheter hub defect that connects both extension catheters. There is a potential…
Is nurse staffing legislation in the public’s interest?
Editor's Note This study led by nurse researchers Linda Aiken, PhD, RN, FAAN, and Karen Lasater, PhD, RN, FAAN, at the University of Pennsylvania School of Nursing, Philadelphia, finds that if New York state enacts nurse staffing legislation currently under consideration, many lives would be saved and shorter hospital stays…
The Joint Commission suicide prevention EP to now include LTAC hospitals
Editor's Note The Joint Commission on July 27 announced that it is revising its National Patient Safety Goal (NPSG) Standard NPSG.15.01.01, element of performance (EP) 1, to now include long-term acute care (LTAC) hospitals, effective January 1, 2023. The change will allow The Joint Commission to score environmental risk assessment…
Free Daily News
- Healthcare employment up in December
- Hospital M&A trends report reveals financial distress, market reorganization
- Study: Patient care experience declined after private equity hospital acquisitions
- Report: Medical student distress rises amid overall healthcare burnout improvement
- Prosthetic insurance coverage disparities persist despite legal protections
- Study: GLP-1 drugs reduce surgical complications in diabetes patients
- United Surgical Partners agrees to $1.48M settlement in 401(k) fee lawsuit
- Healthcare M&A activity set to rebound in 2025 amid stricter state oversight
- High participation in ASCQR program continues, March deadline for reconsideration requests
- Study: Preoperative stereotactic radiosurgery shows promise in brain metastases management